Literature DB >> 21448146

Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria.

Per M Hellström1, Yuri A Saito, Peter Bytzer, Jan Tack, Stefan Mueller-Lissner, Lin Chang.   

Abstract

OBJECTIVES: An international multicenter, prospective, non-interventional, 2-month study characterized acute pain attacks in patients with irritable bowel syndrome (IBS).
METHODS: Adult patients meeting the Rome III IBS diagnostic criteria with a history of ≥ 3 pain attacks per month participated in a survey that captured daily and episodic information regarding IBS symptoms and pain attacks for 2 months. Acute pain attacks were defined as a sudden onset or increase in the intensity of IBS abdominal pain with a minimum intensity of 4 (0-10 scale).
RESULTS: The majority (84%) of the 158 patients taking the survey were women with a mean age of 41 years and time since IBS diagnosis of 5 years. The median pain attack frequency was 5.4 attacks per month and was significantly higher in the IBS with diarrhea (IBS-D, 6.4 per month) group vs. the IBS with constipation (4.4 per month) and the IBS with mixed pattern (5.5 per month) groups (P=0.019). The median pain attack duration was 2.8 h and the median intensity score was 7. The majority of pain attacks resulted in defecation (78%), and occurred more often in IBS-D patients than in other subgroups. The majority of pain attacks (63%) interfered with work and/or daily activities. Medication to manage pain attacks was used by 44% of patients during 29% of attacks. Although used by less than half of all patients, medication helped 66% of attacks treated.
CONCLUSIONS: The frequency of severe pain attacks was 1.4 per week and the majority affected daily activities. However, most of the pain attacks were untreated in IBS patients. Pain attack management is an unmet need of IBS treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21448146     DOI: 10.1038/ajg.2011.78

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

1.  IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment.

Authors:  Olafur S Palsson; Jeffrey S Baggish; Marsha J Turner; William E Whitehead
Journal:  Am J Gastroenterol       Date:  2011-11-08       Impact factor: 10.864

2.  Comparison of electroacupuncture and moxibustion on brain-gut function in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.

Authors:  Ji-meng Zhao; Jin-hua Lu; Xiao-jun Yin; Xing-kui Chen; Yue-hua Chen; Wei-jun Tang; Xiao-ming Jin; Lu-yi Wu; Chun-hui Bao; Huan-gan Wu; Yin Shi
Journal:  Chin J Integr Med       Date:  2015-04-06       Impact factor: 1.978

Review 3.  Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits.

Authors:  Michael Camilleri; Anthony Lembo; David A Katzka
Journal:  Clin Gastroenterol Hepatol       Date:  2017-05-19       Impact factor: 11.382

4.  Subtypes of irritable bowel syndrome in children and adolescents.

Authors:  Mariella M Self; Danita I Czyzewski; Bruno P Chumpitazi; Erica M Weidler; Robert J Shulman
Journal:  Clin Gastroenterol Hepatol       Date:  2014-01-29       Impact factor: 11.382

Review 5.  The global impact of IBS: time to think about IBS-specific models of care?

Authors:  Maura Corsetti; Peter Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2017-07-31       Impact factor: 4.409

6.  Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice.

Authors:  B M R Spiegel; R Bolus; L A Harris; S Lucak; W D Chey; G Sayuk; E Esrailian; A Lembo; H Karsan; K Tillisch; J Talley; L Chang
Journal:  Aliment Pharmacol Ther       Date:  2010-08-30       Impact factor: 8.171

7.  Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study.

Authors:  Eric D Shah; Christopher V Almario; Brennan M Spiegel; William D Chey
Journal:  Am J Gastroenterol       Date:  2020-02       Impact factor: 12.045

Review 8.  What Is New in Rome IV.

Authors:  Max J Schmulson; Douglas A Drossman
Journal:  J Neurogastroenterol Motil       Date:  2017-04-30       Impact factor: 4.924

9.  Determining patient treatment preferences for management of acute pain episodes in irritable bowel syndrome.

Authors:  Christopher V Almario; Samuel Eberlein; Carine Khalil; Brennan M R Spiegel
Journal:  Neurogastroenterol Motil       Date:  2021-04-02       Impact factor: 3.598

10.  A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation.

Authors:  Satish Rao; Anthony J Lembo; Steven J Shiff; Bernard J Lavins; Mark G Currie; Xinwei D Jia; Kelvin Shi; James E MacDougall; James Z Shao; Paul Eng; Susan M Fox; Harvey A Schneier; Caroline B Kurtz; Jeffrey M Johnston
Journal:  Am J Gastroenterol       Date:  2012-11       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.